Data Collective IV GP, LLC
In its 13F for Q1 2025 (holdings as of March 31, 2025, filed May 15, 2025), Data Collective IV GP, LLC reported 5 stock positions worth $86.9 million. Its top holding was Recursion Pharmaceuticals-A (RXRX) at 36.2% of the portfolio, followed by Evolv Technologies (EVLV, 34.8%) and Rocket Lab USA (RKLB, 28.4%). Compared with Q4 2024, it sold out of 1. The biggest sale was an exit from Oklo (OKLO).
- Most Recent 13F
- Q2 2026
- Location
- PALO ALTO, CA
- CIK
- 0001664974
- Portfolio Value
- $86.9M (Q1 2025)
- SEC Filing
- 0001104659-25-048961 ↗ filed May 15, 2025
Holdings Value
Holdings 5 stocks · $86.9M
| RXRX Recursion Pharmaceuticals-A | 36.17% | 5,941,120 | $31.4M | No change |
| EVLV Evolv Technologies Holdings | 34.76% | 9,681,281 | $30.2M | No change |
| RKLB Rocket Lab USA Inc. | 28.35% | 1,377,943 | $24.6M | No change |
| MIND MEDICINE MINDMED INC | 0.68% | 100,350 | $587K | No change |
| ROIV Roivant Sciences Ltd. | 0.04% | 3,875 | $39K | No change |
Portfolio Sells Q4 2024 → Q1 2025
| OKLO Oklo Inc. | Sold out | 0.00% | −49.51 |
Portfolio Buys Q4 2024 → Q1 2025
| None this quarter. | |||
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 4 | $78.6M | EVLV, HQ, RXRX, DFTX |
| Q1 2026 | 4 | $55.9M | EVLV, RXRX, HQ, DFTX |
| Q4 2025 | 3 | $58.5M | EVLV, RXRX, MIND MEDICINE MINDMED INC |
| Q3 2025 | 4 | $68.0M | EVLV, RXRX, MIND MEDICINE MINDMED INC, ROIV |
| Q2 2025 | 5 | $129.9M | EVLV, RKLB, RXRX, MIND MEDICINE MINDMED INC, ROIV |
| Q1 2025 | 5 | $86.9M | RXRX, EVLV, RKLB, MIND MEDICINE MINDMED INC, ROIV |
| Q4 2024 | 6 | $226.3M | OKLO, RXRX, EVLV, RKLB, MIND MEDICINE MINDMED INC |
| Q3 2024 | 6 | $163.5M | OKLO, EVLV, RXRX, RKLB, MIND MEDICINE MINDMED INC |
| Q2 2024 | 6 | $142.7M | OKLO, RXRX, EVLV, RKLB, MIND MEDICINE MINDMED INC |
| Q1 2024 | 5 | $115.3M | RXRX, EVLV, RKLB, MIND MEDICINE MINDMED INC, ROIV |